RACHEL LABERENZ: Open Payments
NPI 1366973422 · ATHENS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 16 payments from 8 companies in 2025. Trend: 2023 $428 · 2024 $388 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $116 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: ELIQUIS, LEQVIO, VYNDAQEL, VERQUVO, JARDIANCE, CAMZYOS, FARXIGA, Repatha.
Industry payments across AL — which companies pay providers there.
